1. Home
  2. CMTV vs VYGR Comparison

CMTV vs VYGR Comparison

Compare CMTV & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CMTV

Community Bancorp. (VT)

N/A

Current Price

$40.25

Market Cap

224.3M

Sector

N/A

ML Signal

N/A

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.48

Market Cap

203.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMTV
VYGR
Founded
N/A
2013
Country
United States
United States
Employees
134
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
224.3M
203.6M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
CMTV
VYGR
Price
$40.25
$3.48
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.50
AVG Volume (30 Days)
12.2K
568.1K
Earning Date
N/A
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,135,000.00
Revenue This Year
N/A
$34.04
Revenue Next Year
N/A
$7.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.53
$2.83
52 Week High
$42.92
$5.55

Technical Indicators

Market Signals
Indicator
CMTV
VYGR
Relative Strength Index (RSI) 57.58 43.51
Support Level $36.36 $3.31
Resistance Level $40.72 $4.29
Average True Range (ATR) 1.84 0.20
MACD 0.31 -0.02
Stochastic Oscillator 81.65 30.77

Price Performance

Historical Comparison
CMTV
VYGR

About CMTV Community Bancorp. (VT)

Community Bancorp Inc is a holding company that provides a complete line of personal and business banking services with personal services and solutions. The company mainly offers Business banking, Commercial real estate lending, residential real estate lending, Retail credit, Municipal and Institutional Banking, and Retail Banking. The company's primary lending products are commercial, real estate, municipal, and consumer loans. The bank offers a complete line of personal and business products and services, along with offerings for non-profit organizations, municipalities, and local governments. The Firm also engages in lending activity outside the area of its branch network, through loan production offices in Burlington, Vermont, and Lebanon, New Hampshire.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: